SCHEMBL3066899

SCHEMBL3066899

CC(C)CC(N)C(=O)N(C(=O)C(N)CC(C)C)C(C(=O)O)C(C)C

nearest known ligand 0.55

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SLC7A5 Q01650 2/20 0.55
SLC1A3 P43003 4/20 0.44
SLC1A2 P43004 4/20 0.44
SLC1A1 P43005 3/20 0.41
RNPEP Q9H4A4 4/20 0.36
CACNA2D1 P54289 2/20 0.36
CACNB3 P54284 1/20 0.36
CACNA1C Q13936 1/20 0.36
PGR P06401 1/20 0.36
ADRA1A P35348 1/20 0.36
HTR2B P41595 1/20 0.36
CACNA2D2 Q9NY47 1/20 0.36
ANPEP P15144 4/20 0.36
DNPEP Q9ULA0 2/20 0.36
LAP3 P28838 4/20 0.34
LARS1 Q9P2J5 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28564227 0.89 SLC7A5 (0.47) SLC7A5SLC1A3SLC1A2SLC1A1RNPEP
SCHEMBL4658496 0.88 SLC7A5 (0.43) SLC7A5SLC1A3SLC1A2SLC1A1RNPEP
SCHEMBL28534814 0.86 SLC7A5 (0.44) SLC7A5SLC1A3SLC1A2SLC1A1RNPEP
SCHEMBL15173245 0.85 SLC7A5 (0.55) SLC7A5SLC1A3SLC1A2SLC1A1RNPEP
SCHEMBL15173244 0.85 SLC7A5 (0.55) SLC7A5SLC1A3SLC1A2SLC1A1RNPEP
SCHEMBL10588085 0.85 SLC7A5 (0.55) SLC7A5SLC1A3SLC1A2SLC1A1RNPEP
SCHEMBL28518732 0.84 ANPEP (0.53) SLC7A5SLC1A3SLC1A2SLC1A1RNPEP
SCHEMBL8585917 0.84 SLC7A5 (0.53) SLC7A5SLC1A3SLC1A2SLC1A1RNPEP
SCHEMBL3056494 0.79 SLC7A5 (0.57) SLC7A5SLC1A3SLC1A2SLC1A1RNPEP
SCHEMBL31116850 0.76 SLC7A5 (0.52) SLC7A5SLC1A3SLC1A2SLC1A1LAP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8443799-B2 Dry powder inhalation system for transpulmonary administration OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2013-05-21 US disclosed
US-8333193-B2 Dry powder inhalation system for transpulmonary administration OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2012-12-18 US disclosed
US-7735485-B2 Dry powder inhalation system for transpulmonary administration OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2010-06-15 US disclosed
US-20090126732-A1 DRY POWDER INHALATION SYSTEM FOR TRANSPULMONARY ADMINISTRATION OTSUKA PHARMACEUTICAL CO., LTD. 2009-05-21 US disclosed
US-20090095293-A1 DRY POWDER INHALATION SYSTEM FOR TRANSPULMONARY ADMINISTRATION OTSUKA PHARMACEUTICAL CO., LTD. 2009-04-16 US disclosed
US-7448379-B2 Inhalation system for transpulmonary administration according to which a freeze-dried composition provided housed in a vessel can be prepared into a form suitable for transpulmonary administration by being made into fine particles at the time of use, and administered by inhalation as is OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2008-11-11 US disclosed
US-20070065371-A2 Novel Dry Powder Inhalation System For Transpulmonary Administration OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-03-22 US disclosed
EP-1402913-B1 DRY POWDER INHALATION SYSTEM FOR TRANSPULMONARY ADMINISTRATION, METHOD OF MANUFACTURING A DRY POWDERED PREPARATION, AND USE OF A FREEZE DRIED COMPOSITION OTSUKA PHARMA CO LTD (JP) 2006-08-23 EP disclosed
EP-1688133-A1 Freeze-dried composition for transpulmonary administration OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-08-09 EP disclosed
EP-1688134-A2 Dry powder inhaler for transpulmonary administration OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-08-09 EP disclosed
US-20060073105-A1 Novel dry powder inhalation system for transpulmonary administration YAMASHITA CHIKAMASA 2006-04-06 US disclosed
EP-1579855-A1 NOVEL DRY POWDER INHALATION SYSTEM FOR TRANSPULMONARY ADMINISTRATION OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-09-28 EP disclosed
EP-1402913-A1 DRY POWDER INHALATION SYSTEM FOR TRANSPULMONARY ADMINISTRATION OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2004-03-31 EP disclosed
US-20030101995-A1 Dry powder inhalation system for transpulmonary administration OTSUKA PHARMACEUTICAL CO., LTD. 2003-06-05 US disclosed